Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Financial Flexibility Index
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Financial Flexibility Index of 0.05x as of December 2025. Free cash flow of CN¥2.18 Billion (operating CF CN¥1.84 Billion minus capex CN¥330.65 Million) represents 0% of total liabilities (CN¥43.39 Billion). Check asset allocation strategy of Guangzhou Baiyunshan Pharmaceutical Hold to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Financial Flexibility Index (2000–2025)
Historical Financial Flexibility Index trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd across 26 annual periods. See working capital to net assets of Guangzhou Baiyunshan Pharmaceutical Hold to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Year-by-year free cash flow to debt coverage for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. For the full company profile including market capitalisation, see market value of Guangzhou Baiyunshan Pharmaceutical Hold.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | CN¥1.50 Billion | CN¥260.23 Million | CN¥43.39 Billion | ▼ -66.8% |
| 2024 | 0.10x | CN¥4.57 Billion | CN¥3.44 Billion | CN¥43.91 Billion | ▼ -23.9% |
| 2023 | 0.14x | CN¥5.73 Billion | CN¥4.10 Billion | CN¥41.91 Billion | ▼ -33.1% |
| 2022 | 0.20x | CN¥8.38 Billion | CN¥7.00 Billion | CN¥41.03 Billion | ▲ +2.6% |
| 2021 | 0.20x | CN¥6.93 Billion | CN¥5.67 Billion | CN¥34.79 Billion | ▲ +329.9% |
| 2020 | 0.05x | CN¥1.46 Billion | CN¥585.19 Million | CN¥31.55 Billion | ▼ -80.7% |
| 2019 | 0.24x | CN¥7.42 Billion | CN¥5.02 Billion | CN¥30.90 Billion | ▲ +19.5% |
| 2018 | 0.20x | CN¥5.70 Billion | CN¥5.22 Billion | CN¥28.34 Billion | ▼ -10.4% |
| 2017 | 0.22x | CN¥2.03 Billion | CN¥1.83 Billion | CN¥9.05 Billion | ▼ -30.8% |
| 2016 | 0.32x | CN¥2.67 Billion | CN¥2.44 Billion | CN¥8.24 Billion | ▼ -5.2% |
| 2015 | 0.34x | CN¥2.46 Billion | CN¥1.94 Billion | CN¥7.19 Billion | ▲ +1.1% |
| 2014 | 0.34x | CN¥2.12 Billion | CN¥1.76 Billion | CN¥6.25 Billion | ▲ +4.7% |
| 2013 | 0.32x | CN¥1.69 Billion | CN¥1.34 Billion | CN¥5.23 Billion | ▲ +16.3% |
| 2012 | 0.28x | CN¥559.14 Million | CN¥506.53 Million | CN¥2.01 Billion | ▲ +319.3% |
| 2011 | -0.13x | CN¥-121.19 Million | CN¥-180.05 Million | CN¥956.09 Million | ▼ -167.7% |
| 2010 | 0.19x | CN¥156.37 Million | CN¥73.17 Million | CN¥835.05 Million | ▼ -70.8% |
| 2009 | 0.64x | CN¥526.95 Million | CN¥439.39 Million | CN¥820.92 Million | ▲ +337.0% |
| 2008 | 0.15x | CN¥133.09 Million | CN¥6.10 Million | CN¥905.99 Million | ▼ -14.2% |
| 2007 | 0.17x | CN¥498.43 Million | CN¥375.74 Million | CN¥2.91 Billion | ▲ +224.9% |
| 2006 | 0.05x | CN¥129.33 Million | CN¥38.88 Million | CN¥2.46 Billion | ▼ -55.4% |
| 2005 | 0.12x | CN¥270.68 Million | CN¥146.32 Million | CN¥2.29 Billion | ▼ -40.9% |
| 2004 | 0.20x | CN¥509.23 Million | CN¥200.54 Million | CN¥2.55 Billion | ▲ +17.1% |
| 2003 | 0.17x | CN¥360.35 Million | CN¥-6.83 Million | CN¥2.11 Billion | ▼ -12.8% |
| 2002 | 0.20x | CN¥342.71 Million | CN¥169.01 Million | CN¥1.75 Billion | ▼ -7.9% |
| 2001 | 0.21x | CN¥300.59 Million | CN¥140.15 Million | CN¥1.41 Billion | ▼ -26.1% |
| 2000 | 0.29x | CN¥450.48 Million | CN¥286.95 Million | CN¥1.57 Billion | — |